Indication for a Single Postoperative Instillation of Chemotherapy in Non-muscle-invasive Bladder Cancer: What Factors Should Be Considered?

被引:6
作者
Babjuk, Marko [1 ,2 ]
Burger, Maximilian [5 ]
Comperat, Eva M. [6 ]
Gontero, Paolo [7 ]
Mostafid, Hugh A. [8 ]
Palou, Joan [9 ]
van Rhijn, Bas W. G. [10 ]
Roupret, Morgan [11 ]
Shariat, Shahrokh F. [1 ,2 ,3 ,4 ]
Sylvester, Richard [12 ]
Zigeunerm, Richard [13 ]
Capoun, Otakar [14 ]
Cohen, Daniel [15 ,16 ]
Dominguez-Escrig, Jose L. [17 ]
Hernandez, Virginia [18 ]
Peyronnet, Benoit [19 ]
Seisen, Thomas [11 ]
Soukup, Viktor [14 ]
机构
[1] Charles Univ Prague, Hosp Motol, Fac Med 2, Dept Urol, Prague, Czech Republic
[2] Med Univ Vienna, Vienna Gen Hosp, Vienna, Austria
[3] Univ Texas Southwestern Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA
[4] Weill Cornell Med Coll, Dept Urol, New York, NY USA
[5] Univ Regensburg, Caritas St Josef Med Ctr, Dept Urol, Regensburg, Germany
[6] Sorbonne Univ, Hop Tenon, AP HP, Dept Pathol, Paris, France
[7] Univ Turin, San Giovanni Battista Hosp, Citta Salute & Sci, Dept Urol, Turin, Italy
[8] Royal Surrey Cty Hosp, Dept Urol, Guildford, Surrey, England
[9] Univ Autonoma Barcelona, Dept Urol, Fundacio Puigvert, Barcelona, Spain
[10] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Urol, Amsterdam, Netherlands
[11] Sorbonne Univ, Hop La Pitie Salpetriere, AP HP, Dept Urol, Paris, France
[12] European Assoc Urol, Guidelines Off, Brussels, Belgium
[13] Med Univ Graz, Dept Urol, Graz, Austria
[14] Charles Univ Prague, Gen Univ Hosp, Fac Med 1, Dept Urol, Prague, Czech Republic
[15] Imperial Coll London, Dept Surg & Canc, London, England
[16] Lister Hosp, East & North Hertfordshire NHS Trust, Dept Urol, Stevenage, Herts, England
[17] Fdn Inst Valenciano Oncol, Serv Urol, Valencia, Spain
[18] Hosp Univ Fdn Alcorcon, Dept Urol, Madrid, Spain
[19] CHU Rennes, Serv Urol, Rennes, France
来源
EUROPEAN UROLOGY FOCUS | 2018年 / 4卷 / 04期
关键词
Bladder cancer; Non-muscle-invasive; Single postoperative instillation of chemotherapy; Indication; INTRAVESICAL CHEMOTHERAPY; TRANSURETHRAL RESECTION; MITOMYCIN-C; RECURRENCE; TUMOR; IMPLANTATION; METAANALYSIS; INHIBITION; MANAGEMENT; CARCINOMA;
D O I
10.1016/j.euf.2018.07.023
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
An early single instillation of intravesical chemotherapy (SICI) used immediately after transurethral resection of the bladder (TURB) can significantly reduce the recurrence rate in selected patients with non-muscle-invasive bladder cancer(NMIBC). SICI should be used in patients with low-risk and with selected intermediate-risk tumours, in particular for multiple primary small papillary tumours, single primary papillary tumours >3 cm, and single recurrent papillary tumours recurring >1 yr after the previous resection. The available data do not support any recommendation to reduce the role of SICI in patients after fluorescence cystoscopy-guided TURB oren bloc TURB. SICI can even provide some benefit inpatients with intermediate-risk tumours subsequently treated with further instillations. During instillation, contraindications should be taken into account and safety measures should be applied. Patient summary: An early single instillation of intravesical chemotherapy immediately after transurethral resection of the bladder can significantly reduce the recurrence rate in selected patients with non-muscle-invasive bladder cancer. It should be used in patients with low-risk and selected intermediate-risk tumours. (C) 2018 European Association of Urology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:525 / 528
页数:4
相关论文
共 21 条
  • [1] Perioperative Intravesical Chemotherapy in Non-Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis
    Ahern, Michael R.
    Owusu, Richmond A.
    Anderson, Mark R.
    Rampersaud, Edward N.
    Inman, Brant A.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013, 11 (04): : 477 - 484
  • [2] EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
    Babjuk, Marko
    Boehle, Andreas
    Burger, Maximilian
    Capoun, Otakar
    Cohen, Daniel
    Comperat, Eva M.
    Hernandez, Virginia
    Kaasinen, Eero
    Palou, Joan
    Roupret, Morgan
    van Rhijn, Bas W. G.
    Shariat, Shahrokh F.
    Soukup, Viktor
    Sylvester, Richard J.
    Zigeuner, Richard
    [J]. EUROPEAN UROLOGY, 2017, 71 (03) : 447 - 461
  • [3] A single instillation of epirubicin after transurethral resection of bladder tumors prevents only small recurrences
    Berrum-Svennung, Ingela
    Granfors, Torvald
    Jahnson, Staffan
    Boman, Hans
    Holmang, Sten
    [J]. JOURNAL OF UROLOGY, 2008, 179 (01) : 101 - 105
  • [4] Value of an Immediate Intravesical Instillation of Mitomycin C in Patients with Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Randomised Study in 2243 patients
    Bosschieter, Judith
    Nieuwenhuijzen, Jakko A.
    van Ginkel, Tessa
    Vis, Andre N.
    Witte, Birgit
    Newling, Don
    Beckers, Goedele M. A.
    van Moorselaar, R. Jeroen A.
    [J]. EUROPEAN UROLOGY, 2018, 73 (02) : 226 - 232
  • [5] Inhibition of tumor implantation by intravesical gemcitabine in a murine model of superficial bladder cancer
    Brocks, CP
    Büttner, H
    Böhle, A
    [J]. JOURNAL OF UROLOGY, 2005, 174 (03) : 1115 - 1118
  • [6] Destruction of the bladder by single dose Mitomycin C for low-stage transitional cell carcinoma (TCC) - avoidance, recognition, management and consent
    Elmamoun, Mamoun H.
    Christmas, Tim J.
    Woodhouse, Christopher R. J.
    [J]. BJU INTERNATIONAL, 2014, 113 (5B) : E34 - E38
  • [7] Long-Term Decrease in Bladder Cancer Recurrence with Hexaminolevulinate Enabled Fluorescence Cystoscopy
    Grossman, H. Barton
    Stenzl, Arnulf
    Fradet, Yves
    Mynderse, Lance A.
    Kriegmair, Martin
    Witjes, J. Alfred
    Soloway, Mark S.
    Karl, Alexander
    Burger, Maximilian
    [J]. JOURNAL OF UROLOGY, 2012, 188 (01) : 58 - 62
  • [8] Discrepancy Between European Association of Urology Guidelines and Daily Practice in the Management of Non-muscle-invasive Bladder Cancer: Results of a European Survey
    Hendricksen, Kees
    Aziz, Atiqullah
    Bes, Perrine
    Chun, Felix K. -H.
    Dobruch, Jakub
    Kluth, Luis A.
    Gontero, Paolo
    Necchi, Andrea
    Noon, Aidan P.
    van Rhijn, Bas W. G.
    Rink, Michael
    Roghmann, Florian
    Roupret, Morgan
    Seiler, Roland
    Shariat, Shahrokh F.
    Qvick, Brian
    Babjukm, Marek
    Xylinas, Evanguelos
    [J]. EUROPEAN UROLOGY FOCUS, 2019, 5 (04): : 681 - 688
  • [9] Management of low grade papillary bladder tumors
    Herr, Harry W.
    Donat, S. Machele
    Reuter, Victor E.
    [J]. JOURNAL OF UROLOGY, 2007, 178 (04) : 1201 - 1205
  • [10] Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non-Muscle-Invasive Bladder Cancer
    Holmang, Sten
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (05) : 458 - 463